Elida Estate (Coffea arabica)

Elida Estate is a premium Coffea arabica cultivar grown at high altitudes in Panama's Boquete region. This coffee variety contains standard coffee compounds like caffeine and chlorogenic acids but lacks specific clinical research on unique health benefits.

Origin & History

Elida Estate is a specialty coffee farm in Boquete, Panama, established in 1918 and operated by the Lamastus family, cultivating Arabica coffee varieties (primarily Typica, Geisha, and Catuai) at altitudes of 1,700-2,000 meters. The coffee is processed using natural, washed, or honey methods and is known for flavor profiles including tropical fruits, black berry notes, and caramel sweetness.

Historical & Cultural Context

Established in 1918, Elida Estate has been operated by the Lamastus family for over a century as a specialty coffee farm. No traditional medicinal or cultural health uses are documented in the available research.

Health Benefits

• No clinical health benefits documented in available research - only agricultural and culinary information provided
• No human studies or clinical trials found in the research dossier
• No biomedical data available for this specific coffee cultivar
• No safety or efficacy data presented in the available sources
• No traditional medicinal uses documented in the provided research

How It Works

As a Coffea arabica variety, Elida Estate contains caffeine which acts as an adenosine receptor antagonist, blocking A1 and A2A receptors to promote alertness. The chlorogenic acids present may inhibit glucose-6-phosphatase and affect glucose metabolism. However, no specific mechanisms have been studied for this particular cultivar.

Scientific Research

No clinical trials, meta-analyses, or PubMed-indexed studies were found in the research dossier. The available information consists solely of agricultural and culinary descriptions of this coffee estate, with no biomedical or pharmacological data provided.

Clinical Summary

No clinical trials or human studies have been conducted specifically on Elida Estate coffee cultivar. Available research focuses solely on agricultural characteristics and cup quality rather than health outcomes. General coffee research cannot be directly applied to this specific variety without dedicated studies. The lack of biomedical data limits evidence-based health claims for this cultivar.

Nutritional Profile

Elida Estate coffee (Coffea arabica, grown in Boquete, Panama at high altitude ~1,900m) shares the general nutritional composition of specialty-grade washed Geisha and other premium arabica cultivars, with some site-specific distinctions. Per 240ml brewed cup (standard drip, ~8.5g grounds): Calories ~2 kcal, Carbohydrates ~0g (trace), Protein ~0.3g, Fat ~0g (filtered preparation removes most oils; unfiltered/French press retains diterpene oils cafestol and kahweol at ~2–4mg per cup). Caffeine: arabica cultivars typically yield 0.8–1.4% caffeine by dry weight; at standard brew ratios, a 240ml cup delivers approximately 80–120mg caffeine, though Geisha-type genetics at high altitude tend toward the lower end (~80–100mg). Chlorogenic acids (CGAs): primary bioactive compounds, predominantly 5-O-caffeoylquinic acid (5-CQA); green arabica beans contain ~6–9% CGA by dry weight, reduced to ~1–4% after light-to-medium roasting typical of specialty processing; per brewed cup approximately 70–200mg total CGAs depending on roast level and brew method. Trigonelline: ~0.5–1.0% dry weight in green beans, partially degraded to niacin (vitamin B3) during roasting; brewed cup contributes ~25–60mg trigonelline and ~1–3mg niacin. Potassium: ~116mg per 240ml brewed cup (one of the more nutritionally significant minerals in brewed coffee). Magnesium: ~7–10mg per cup. Manganese: ~0.05–0.1mg per cup. Riboflavin (B2): ~0.2mg per cup. Antioxidant capacity (FRAP/DPPH): specialty arabica brewed coffee demonstrates high antioxidant activity, estimated 200–550mg Trolox equivalents per cup; high-altitude Elida Estate lots may trend toward higher phenolic content due to slower cherry maturation increasing CGA accumulation. Lipids (diterpenes cafestol/kahweol): largely removed by paper filtration; relevant only in espresso (~0.4–4.8mg per shot) or unfiltered preparations. Bioavailability notes: CGAs are partially absorbed in the small intestine (~33%) with remainder metabolized by colonic microbiota to bioavailable phenolic metabolites (e.g., ferulic acid, caffeic acid); caffeine bioavailability is near 100% with peak plasma concentration at 30–60 minutes post-consumption; potassium and magnesium from coffee are generally well absorbed. No cultivar-specific nutritional laboratory analysis for Elida Estate lots is publicly documented; values reflect high-altitude specialty arabica composition with Geisha-lineage estimates where applicable.

Preparation & Dosage

No clinically studied dosage ranges available in the research. The dossier contains only agricultural information about coffee cultivation and processing methods, not biomedical dosing data. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient biomedical data to recommend synergistic ingredients

Safety & Interactions

Safety data specific to Elida Estate cultivar is not available in published research. General coffee safety guidelines would likely apply, including potential interactions with stimulant medications and contraindications for individuals with caffeine sensitivity. Pregnant women should follow standard caffeine intake recommendations. Without specific studies, unique safety considerations for this cultivar cannot be determined.